If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcado Regulatory News (OCDO)

Share Price Information for Ocado (OCDO)

Share Price is delayed by 15 minutes
Get Live Data
172.30    -1.10 (-0.63%)
Bid:
172.00
Ask:
172.50
Spread: 0.50 (0.291%)
Market Cap: £1.44b
OCDO Live PriceLast checked at - London Stock Exchange

Intraday Ocado Share Chart

Director/PDMR Shareholding

1 Jul 2016 15:40

RNS Number : 0413D
Ocado Group PLC
01 July 2016
 

DIRECTOR/PDMR SHAREHOLDINGOCADO GROUP PLC1 July 2016

 

 

Ocado Group plc 

Director/PDMR Notification

 

Ocado Group plc (the "Company") announces that it has received notification pursuant to the FCA's Disclosure and Transparency Rules 3.1.2R, that Duncan Tatton-Brown, an executive director of the Company, has purchased ordinary shares in the Company.

 

Mr Tatton-Brown purchased 100,000 shares at a price of 226.70 pence per share on 1 July 2016.

 

The shares purchased represent 0.016% of the Company's issued share capital. Following these purchases, Mr Tatton-Brown holds 624,604 ordinary shares in the Company, which represents 0.099% of the Company's issued share capital.

 

For the purposes of DTR 3.1.3, the transactions took place in the United Kingdom.

 

Enquiries:

Neill AbramsCompany SecretaryOcado Group plcTitan Court3 Bishops SquareHatfield Business ParkHatfield, Hertfordshire AL10 9NEFax: +44 (0)1707 227 997email: company.secretary@ocado.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUAOSRNWABRAR
Date   Source Headline
17th Sep 20215:35 pmRNSDirector/PDMR Shareholding
14th Sep 20217:00 amRNSTrading Statement
1st Sep 20211:42 pmRNSTotal Voting Rights
24th Aug 20217:00 amRNSDirectorate Change
18th Aug 20212:54 pmRNSDirector/PDMR Shareholding
2nd Aug 202112:20 pmRNSTotal Voting Rights
28th Jul 20213:43 pmRNSDirector/PDMR Shareholding
27th Jul 20213:14 pmRNSBlock listing Interim Review
21st Jul 20211:45 pmRNSDirector/PDMR Shareholding
19th Jul 20215:34 pmRNSDirector/PDMR Shareholding
16th Jul 202112:34 pmRNSDirector/PDMR Shareholding
6th Jul 20217:02 amRNSAnnouncement of partnership with Alcampo
6th Jul 20217:00 amRNSHalf-year Report
1st Jul 20215:06 pmRNSTotal Voting Rights
1st Jul 20214:17 pmRNSDirector/PDMR Shareholding
15th Jun 20215:31 pmRNSDirector/PDMR Shareholding
1st Jun 202112:26 pmRNSTotal Voting Rights
18th May 202110:09 amRNSDirector/PDMR Shareholding
13th May 20216:14 pmRNSResult of AGM
13th May 20217:00 amRNSHolding(s) in Company
11th May 202112:44 pmRNSDirector/PDMR Shareholding
7th May 20216:26 pmRNSDirector/PDMR Shareholding
4th May 20215:42 pmRNSTotal Voting Rights
28th Apr 20214:44 pmRNSDirector/PDMR Shareholding
23rd Apr 20215:22 pmRNSDirector/PDMR Shareholding
16th Apr 20213:39 pmRNSDirector/PDMR Shareholding
16th Apr 20217:00 amRNSOcado Invests in Oxbotica
13th Apr 20219:04 amRNSChange of Director's Details
1st Apr 202111:17 amRNSTotal Voting Rights
25th Mar 20218:00 amRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSDirector/PDMR Shareholding
22nd Mar 20216:27 pmRNSDirector/PDMR Shareholding
22nd Mar 20216:21 pmRNSDirector/PDMR Shareholding
22nd Mar 202112:34 pmRNSDirector/PDMR Shareholding
22nd Mar 202110:06 amRNSDirector/PDMR Shareholding
18th Mar 20219:25 amRNSDirector/PDMR Shareholding
18th Mar 20217:00 amRNSTrading Statement
9th Mar 20214:24 pmRNSAdditional Listing
1st Mar 20213:59 pmRNSTotal Voting Rights
25th Feb 20217:00 amRNSHolding(s) in Company
17th Feb 20216:15 pmRNSDirector/PDMR Shareholding
16th Feb 20213:24 pmRNSNotice of AGM
15th Feb 20217:15 amRNSDirectorate Appointment Date
12th Feb 20212:54 pmRNSDirector/PDMR Shareholding
10th Feb 20214:05 pmRNSDirector/PDMR Shareholding
9th Feb 202112:00 pmRNSAnnual Financial Report
9th Feb 20217:00 amRNSFinal Results
2nd Feb 20218:57 amRNSDirectorate Change
1st Feb 20212:20 pmRNSTotal Voting Rights
27th Jan 20219:05 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.